Clinical Research in Cardiology

, Volume 97, Issue 5, pp 298–305 | Cite as

Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock

  • Marianne Debrunner
  • Ernst Schuiki
  • Elisabeth Minder
  • Edwin Straumann
  • Barbara Naegeli
  • Raymond Mury
  • Osmund Bertel
  • Jürgen Frielingsdorf
ORIGINAL PAPER

Abstract

Background

Inflammatory response is an important feature of acute coronary syndromes and myocardial infarction (MI). The prognostic value of proinflammatory cytokines in patients with acute MI complicated by cardiogenic shock is unknown.

Methods and results

In 41 patients admitted with acute MI (age 60 ± 11 years, six females, 19 Killip class IV) serial plasma concentration of tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra) were measured. Seven patients with cardiogenic shock (CS) developed a systemic inflammatory response syndrome (SIRS). Patients with CS—particularly those who developed SIRS—showed significantly higher cytokine levels than patients with uncomplicated MI. In patients with CS and SIRS peak levels of IL-1Ra were 223,973 pg/ml, IL-6 252.8 pg/ml and TNF-α 7.0 pg/ml. In CS without SIRS IL-1Ra levels were 19,988 pg/ml, IL-6 109.3 pg/ml and TNF-α 3.8 pg/ml. In uncomplicated MI peak IL-1Ra levels were 1,088 pg/ml, IL-6 34.1 pg/ml and TNF-α 2.6 pg/ml.

Conclusions

The inflammation-associated cytokines TNF-α, IL-6 and IL-1Ra are significantly elevated in patients with MI complicated by CS when compared to patients with uncomplicated MI. Among shock-patients IL-1Ra levels are promising diagnostic markers for early identification of patients developing SIRS, heralding a poor outcome.

Key words

interleukins inflammation infarction prognosis shock 

References

  1. 1.
    Akira S, Hirano T, Taga T et al. (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860–2867PubMedGoogle Scholar
  2. 2.
    Arai KI, Lee F, Miyajima A et al. (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783–836PubMedCrossRefGoogle Scholar
  3. 3.
    Biasucci LM (1996) Elevated Levels of Interleukin-6 in Unstable Angina. Circulation 94:874–877PubMedGoogle Scholar
  4. 4.
    Biasucci LM, Liuzzo G, Fantuzzi G et al. (1999) Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99:2079–2084PubMedGoogle Scholar
  5. 5.
    Cannon JG, Tompkins RG, Gelfand JA et al. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79–84PubMedGoogle Scholar
  6. 6.
    Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Int Med 119:771–778PubMedGoogle Scholar
  7. 7.
    Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503–508PubMedCrossRefGoogle Scholar
  8. 8.
    Fischer E, Van Zee KJ, Marano MA et al. (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196–2200PubMedGoogle Scholar
  9. 9.
    Gabay C (2002) Cytokine inhibitors in the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2:135–149PubMedCrossRefGoogle Scholar
  10. 10.
    Garces K (2001) Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis. Issues Emerg Health Technol 1–4Google Scholar
  11. 11.
    Ghezzi P, Dinarello CA, Bianchi M et al. (1991) Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3:189–194PubMedCrossRefGoogle Scholar
  12. 12.
    Granowitz EV, Santos AA, Poutsiaka DD et al. (1991) Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338:1423–1424PubMedCrossRefGoogle Scholar
  13. 13.
    Hasdai D, Holmes DR Jr., Topol EJ et al. (1999) Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J 20:128–135PubMedCrossRefGoogle Scholar
  14. 14.
    Hegewisch S, Weh HJ, Hossfeld DK (1990) TNF-induced cardiomyopathy. Lancet 335:294–295PubMedCrossRefGoogle Scholar
  15. 15.
    Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A et al. (1999) Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest 115:1170–1174PubMedCrossRefGoogle Scholar
  16. 16.
    Hirschl MM, Gwechenberger M, Binder T et al. (1996) Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J 17:1852–1859PubMedGoogle Scholar
  17. 17.
    Hochman JS, Sleeper LA, Webb JG et al. (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634PubMedCrossRefGoogle Scholar
  18. 18.
    Hochman JS, Sleeper LA, White HD et al. (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192PubMedCrossRefGoogle Scholar
  19. 19.
    Kohsaka S, Menon V, Lowe AM et al. (2005) Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165:1643–1650PubMedCrossRefGoogle Scholar
  20. 20.
    Levine B, Kalman J, Mayer L et al. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241PubMedGoogle Scholar
  21. 21.
    Mantovani A, Bussolino F, Dejana E (1992) Cytokine regulation of endothelial cell function. FASEB J 6:2591–2599PubMedGoogle Scholar
  22. 22.
    Millar AB, Foley NM, Singer M et al. (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712–714PubMedCrossRefGoogle Scholar
  23. 23.
    Moser R, Schleiffenbaum B, Groscurth P et al. (1989) Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83:444–455PubMedCrossRefGoogle Scholar
  24. 24.
    Neumann FJ, Ott I, Gawaz M et al. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748–755PubMedGoogle Scholar
  25. 25.
    Schuler J, Maier B, Behrens S et al. (2006) Present treatment of acute myocardial infarction in patients over 75 years. Clin Res Cardiol 95:360–367PubMedCrossRefGoogle Scholar
  26. 26.
    Shigematsu S (1998) Therapeutic potential of interleukin-1 receptor antagonist in inflammatory bowel disease. Kurume Med J 45:175–179PubMedGoogle Scholar
  27. 27.
    Sturk A, Hack CE, Aarden LA et al. (1992) Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 119:574–579PubMedGoogle Scholar
  28. 28.
    Suffredini AF, Fromm RE, Parker MM et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280–287PubMedGoogle Scholar
  29. 29.
    Torre-Amione G, Kapadia S, Lee J et al. (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711PubMedGoogle Scholar
  30. 30.
    Vaddi K (1994) Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease. Circulation 90:694–699PubMedGoogle Scholar
  31. 31.
    van der Poll T, Levi M, Hack CE et al. (1994) Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179:1253–1259PubMedCrossRefGoogle Scholar
  32. 32.
    Werra Id. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factro receptors, and procalcitonin concentrations: compaision in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Marianne Debrunner
    • 1
  • Ernst Schuiki
    • 1
  • Elisabeth Minder
    • 2
  • Edwin Straumann
    • 1
  • Barbara Naegeli
    • 1
  • Raymond Mury
    • 1
  • Osmund Bertel
    • 1
  • Jürgen Frielingsdorf
    • 1
  1. 1.Division of Cardiology, Department of Internal Medicine Stadtspital TriemliZurichSwitzerland
  2. 2.Central LaboratoryStadtspital TriemliZurichSwitzerland

Personalised recommendations